Should You Invest In Vertex Pharmaceuticals Incorporated?

Get the facts about trading Vertex Pharmaceuticals Incorporated before you start. Discuss investment strategies, review market research, and get real-time updates

1,073,537 Vertex Pharmaceuticals Incorporated positions opened on eToro

Buy VRTX
Sell VRTX
VRTXVertex Pharmaceuticals Incorporated
183.46-3.57 ( -1.91%)
AAPL
AAPLApple
148.69 (-0.53%)
buy
GOOG
GOOGAlphabet
2773.11 (-2.91%)
buy
FB
FBFacebook
324.64 (-5.05%)
buy
MSFT
MSFTMicrosoft
308.93 (-0.51%)
buy
TWTR
TWTRTwitter
62.23 (-4.83%)
buy

Vertex Pharmaceuticals Incorporated was founded on January 4, 1989 and is headquartered in Boston, Massachusetts. A pharmaceuticals company, it is focused on researching and marketing biotechnology solutions for the treatment of cystic fibrosis. The company also operates advanced independent research and development programs in the areas of pain and neurology. Vertex Pharmaceuticals works in collaboration with Cystic Fibrosis Foundation Therapeutics Incorporated; CRISPR Therapeutics AG, and other organisations, and markets its products mainly to specialty pharmacy providers in North America, as well as global government-owned customers. Interested in trading this instrument? Follow it for news and updates.

Buy VRTX Now
Sell VRTX Now

Historical Price Charts

Discover the eToro Advantage

Use eToro's advanced risk management tools to protect your positions. Enjoy hassle-free deposits and withdrawals, instant execution of trades and a free $100,000 demo account to practice your strategy.

Volatility means opportunity! Watch price changes reflect directly onto your portfolio

Start trading within minutes - no physical purcase delays

Benefit from falling prices as well as rising prices. Buy or sell instantly

Zero commission is available to clients of eToro (Europe) Ltd., eToro (UK) Ltd. and eToro AUS Capital Limited (AFSL 491139).

Zero commission means that no broker fee will be charged when opening or closing the position. Other fees apply including FX fees on non-USD deposits and withdrawals. For additional information regarding fees, click here. Your capital is at risk.

eToro Service ARSN 637 489 466 operated by Gleneagle Asset Management ACN 103 162 278 AFSL 226199 and promoted by eToro AUS Capital Limited ACN 612 791 803 AFSL 491139. Investing in shares via a managed investment scheme does not result in direct ownership of the underlying assets. The scheme has legal ownership, the investor has beneficial ownership i.e. the shares are held on your behalf. As the scheme has legal ownership, you have no rights in the securities, including voting rights. Shares are non transferable. Your capital is at risk. Zero commission share trading is only available on limited stock exchanges. All other shares are offered as OTC Derivatives, and include commission. This information is general only and has been prepared without taking your objectives, financial situation or needs into account. You should obtain independent advice and consider our Product Disclosure Statement (PDS) before transacting.

eToro (Europe) Ltd., a Financial Services Company authorised and regulated by the Cyprus Securities Exchange Commission (CySEC) under the license # 109/10.

eToro (UK) Ltd, a Financial Services Company Authorised and regulated by the Financial Conduct Authority (FCA) under the license FRN 583263.

eToro (Seychelles) Ltd. is licenced by the Financial Services Authority Seychelles (“FSAS”) to provide broker-dealer services under the Securities Act 2007 License #SD076

Start Trading
Zero-commission means that no broker fee will be charged when opening or closing the position and does not apply to short or leveraged positions. Other fees apply. Your capital is at risk. For more information, visit etoro.com/trading/fees.got it